Cargando…

Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury

Serum creatinine measurement demonstrates a poor specificity and sensitivity for the early diagnosis of acute kidney injury (AKI) in patients with cirrhosis. The existing model for end‐stage liver disease (MELD) score reveals multiple pitfalls in critically ill patients with cirrhosis and acute kidn...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiao‐Dong, Chen, Qin‐Fen, Sun, Dan‐Qin, Zheng, Chen‐Fei, Liang, Dong‐Jie, Zhou, Jian, Wang, Song‐Jie, Liu, Wen‐Yue, Van Poucke, Sven, Wang, Xiao‐Dong, Shi, Ke‐Qing, Huang, Wei‐Jian, Zheng, Ming‐Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678914/
https://www.ncbi.nlm.nih.gov/pubmed/29404491
http://dx.doi.org/10.1002/hep4.1076
_version_ 1783277536179912704
author Zhou, Xiao‐Dong
Chen, Qin‐Fen
Sun, Dan‐Qin
Zheng, Chen‐Fei
Liang, Dong‐Jie
Zhou, Jian
Wang, Song‐Jie
Liu, Wen‐Yue
Van Poucke, Sven
Wang, Xiao‐Dong
Shi, Ke‐Qing
Huang, Wei‐Jian
Zheng, Ming‐Hua
author_facet Zhou, Xiao‐Dong
Chen, Qin‐Fen
Sun, Dan‐Qin
Zheng, Chen‐Fei
Liang, Dong‐Jie
Zhou, Jian
Wang, Song‐Jie
Liu, Wen‐Yue
Van Poucke, Sven
Wang, Xiao‐Dong
Shi, Ke‐Qing
Huang, Wei‐Jian
Zheng, Ming‐Hua
author_sort Zhou, Xiao‐Dong
collection PubMed
description Serum creatinine measurement demonstrates a poor specificity and sensitivity for the early diagnosis of acute kidney injury (AKI) in patients with cirrhosis. The existing model for end‐stage liver disease (MELD) score reveals multiple pitfalls in critically ill patients with cirrhosis and acute kidney injury (CAKI). The aim of this study was to re‐evaluate the role of creatinine values in the existing MELD score and to develop a novel score for CAKI, named the “acute kidney injury–model for end‐stage liver disease score” (AKI‐MELD score). We extracted 651 CAKI from the Multiparameter Intelligent Monitoring in Intensive Care database. A time‐dependent Cox regression analysis was performed for developing remodeled MELD scores (Reweight‐MELD score, Del‐Cr‐MELD score, and AKI‐MELD score). The area under the receiver operating characteristic curve provided the discriminative power of scoring models related to outcome. The hazard ratio of creatinine was 1.104 (95% confidence interval [CI], 0.945‐1.290; P = 0.211). Reweight‐MELD score and Del‐Cr‐MELD score (decreasing the weight of creatinine) were superior to the original MELD score (all P < 0.001). The new AKI‐MELD score consists of bilirubin, the international normalized ratio, and the ratio of creatinine in 48 hours to creatinine at admission. It had competitive discriminative ability for predicting mortality (area under the receiver operating characteristic curve, 0.720 [95% CI, 0.653‐0.762] at 30 days, 0.688 [95% CI, 0.630‐0.742] at 90 days, and 0.671 [95% CI, 0.612‐0.725] at 1 year). Further, AKI‐MELD score had significantly higher predictive ability in comparison with MELD score, MELD‐Na score, and Updated MELD score (all P < 0.001). Conclusion: The predictive value of creatinine for CAKI should be re‐evaluated. AKI‐MELD score is a potentially reliable tool to determine the prognosis for mortality of CAKI. (Hepatology Communications 2017;1:748–756)
format Online
Article
Text
id pubmed-5678914
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56789142018-02-05 Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury Zhou, Xiao‐Dong Chen, Qin‐Fen Sun, Dan‐Qin Zheng, Chen‐Fei Liang, Dong‐Jie Zhou, Jian Wang, Song‐Jie Liu, Wen‐Yue Van Poucke, Sven Wang, Xiao‐Dong Shi, Ke‐Qing Huang, Wei‐Jian Zheng, Ming‐Hua Hepatol Commun Original Articles Serum creatinine measurement demonstrates a poor specificity and sensitivity for the early diagnosis of acute kidney injury (AKI) in patients with cirrhosis. The existing model for end‐stage liver disease (MELD) score reveals multiple pitfalls in critically ill patients with cirrhosis and acute kidney injury (CAKI). The aim of this study was to re‐evaluate the role of creatinine values in the existing MELD score and to develop a novel score for CAKI, named the “acute kidney injury–model for end‐stage liver disease score” (AKI‐MELD score). We extracted 651 CAKI from the Multiparameter Intelligent Monitoring in Intensive Care database. A time‐dependent Cox regression analysis was performed for developing remodeled MELD scores (Reweight‐MELD score, Del‐Cr‐MELD score, and AKI‐MELD score). The area under the receiver operating characteristic curve provided the discriminative power of scoring models related to outcome. The hazard ratio of creatinine was 1.104 (95% confidence interval [CI], 0.945‐1.290; P = 0.211). Reweight‐MELD score and Del‐Cr‐MELD score (decreasing the weight of creatinine) were superior to the original MELD score (all P < 0.001). The new AKI‐MELD score consists of bilirubin, the international normalized ratio, and the ratio of creatinine in 48 hours to creatinine at admission. It had competitive discriminative ability for predicting mortality (area under the receiver operating characteristic curve, 0.720 [95% CI, 0.653‐0.762] at 30 days, 0.688 [95% CI, 0.630‐0.742] at 90 days, and 0.671 [95% CI, 0.612‐0.725] at 1 year). Further, AKI‐MELD score had significantly higher predictive ability in comparison with MELD score, MELD‐Na score, and Updated MELD score (all P < 0.001). Conclusion: The predictive value of creatinine for CAKI should be re‐evaluated. AKI‐MELD score is a potentially reliable tool to determine the prognosis for mortality of CAKI. (Hepatology Communications 2017;1:748–756) John Wiley and Sons Inc. 2017-08-01 /pmc/articles/PMC5678914/ /pubmed/29404491 http://dx.doi.org/10.1002/hep4.1076 Text en © 2017 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Zhou, Xiao‐Dong
Chen, Qin‐Fen
Sun, Dan‐Qin
Zheng, Chen‐Fei
Liang, Dong‐Jie
Zhou, Jian
Wang, Song‐Jie
Liu, Wen‐Yue
Van Poucke, Sven
Wang, Xiao‐Dong
Shi, Ke‐Qing
Huang, Wei‐Jian
Zheng, Ming‐Hua
Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
title Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
title_full Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
title_fullStr Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
title_full_unstemmed Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
title_short Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
title_sort remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678914/
https://www.ncbi.nlm.nih.gov/pubmed/29404491
http://dx.doi.org/10.1002/hep4.1076
work_keys_str_mv AT zhouxiaodong remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT chenqinfen remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT sundanqin remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT zhengchenfei remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT liangdongjie remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT zhoujian remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT wangsongjie remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT liuwenyue remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT vanpouckesven remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT wangxiaodong remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT shikeqing remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT huangweijian remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury
AT zhengminghua remodelingthemodelforendstageliverdiseaseforpredictingmortalityriskincriticallyillpatientswithcirrhosisandacutekidneyinjury